drstockmann
Sunhttp://www.scivee.tv/node/7029
“Antiviral treatment strategies in Chronic Fatigue Syndrome” International Symposium on Viruses in CFS & Post-viral Fatigue A satellite meeting of the 6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA Day 4 – June 23, 2008 – Clinician Forum Session.
Nexavir (Kutapressin) omtales ca 5 minutter ut i dette opptaket.
Abstract kan leses og lastes ned her.
“Kutapressin administered daily subcutaneously for at least 6 months in combination with B12 (= peroxynitrate scavenger) has a 70% response rate in our practice. Other clinicians have reported similar results with Kutapressin. A pilot study with Isoprinosine (2003) showed that it may benefit a subgroup of patients. Recently, Thymalfasin was added as an alternative for the above. Fourteen weeks of therapy seem to result in similar positive responses.“
